Back
Amarin Corp. Plc 10K Form
Sell
43
AMRN
Amarin Corp. Plc
Last Price:
$16.47
Seasonality Move:
1.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | AMRN/Amarin Corp. Plc Quarterly |
| 2023-11-01 | 10Q | AMRN/Amarin Corp. Plc Quarterly |
| 2023-08-02 | 10Q | AMRN/Amarin Corp. Plc Quarterly |
| 2023-05-03 | 10Q | AMRN/Amarin Corp. Plc Quarterly |
| 2022-10-27 | 10Q | AMRN/Amarin Corp. Plc Quarterly |
| 2022-08-03 | 10Q | AMRN/Amarin Corp. Plc Quarterly |
Receive AMRN News And Ratings
See the #1 stock for the next 7 days that we like better than AMRN
AMRN Financial Statistics
Sales & Book Value
| Annual Sales: | $228.7M |
|---|---|
| Cash Flow: | $-12.8M |
| Price / Cash Flow: | 266.49 |
| Annual Sales: | $22.06 |
| Price / Book: | 0.74 |
Profitability
| EPS (TTM): | -4.16510 |
|---|---|
| Net Income (TTM): | $-85.9M |
| Gross Margin: | $78.4M |
| Return on Equity: | -17.79% |
| Return on Assets: | -12.56% |
Amarin Corp. Plc Earnings Forecast
Key Amarin Corp. Plc Financial Ratios
-
The Gross Profit Margin over the past 32 years for AMRN is 34.28%.
-
The Selling, General & Administrative Expenses for AMRN have been equal to 60.43% of Gross Profit Margin.
-
The Research & Development expenses have been 7.81% of Revenue.
-
The Net Earning history of AMRN is -35.95% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 18 years.
Amarin Corp. Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AMRN |
| CUSIP: | 023111 |
| Website: | amarincorp.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 3.45 |
| Quick Ratio: | 2.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 27.58 |
AMRN Technical Analysis vs Fundamental Analysis
Sell
43
Amarin Corp. Plc (AMRN)
is a Sell
Is Amarin Corp. Plc a Buy or a Sell?
-
Amarin Corp. Plc stock is rated a SellThe current Amarin Corp. Plc [AMRN] share price is $16.29. The Score for AMRN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.